Extended Data Fig. 8: Supplementary crystal structures and electron density maps.
From: Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation
a, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT1(E17K)–3 cocrystallized without added Zn2+. b, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT1(E17K)–3 with added ZnSO4 (2 equiv). c, Cocrystal structure of AKT1(E17K) bound to salicylaldehyde 4 (grey) at 1.9 Å resolution. Yellow dashes, hydrogen bonds; orange dashes, π-stacking; black dashes, Zn2+-chelate interactions. d, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT1(E17K)–4. e, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT1(E17K) labelled with iodoacetamide and cocrystallized with compound 3 (Zn2+-free). f, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT1(WT)–3. g, Cocrystal structure of AKT2(WT) bound to salicylaldehyde 3 (grey) at 2.0 Å resolution. Yellow dashes, hydrogen bonds; orange dashes, π-stacking. h, Ligand electron density map (2Fo-Fc, 1.0 σ) for AKT2(WT)–3.
